When cultured in vitro, peritoneal macrophages, obtained from mice previously inoculated with bacillus
The precise mechanism by which the host defense to malignant tumors is mediated in vivo is not known. Cancer cells could trigger an immune response, which in turn could limit the development of the tumor. If this mechanism is not operative, it is possible to induce nonspecific resistance to cancer cells therapeutically. Nitric oxide (NO)-mediated mechanisms of cytotoxicity have mainly been studied in vitro (1) (2) (3) . When cultured in vitro, peritoneal macrophages obtained from mice previously inoculated with bacillus Calmette-Gudrin (BCG) release NO, which is cytostatic and/or cytolytic for tumor cells (4, 5) . This in vitro cytostatic and/or cytolytic activity is also observed after activation of the macrophages by cytokines (6, 7) . NO produced by the activated macrophages is responsible for this cytostatic and/or cytolytic activity (1) (2) (3) . Interferon 'y (IFN-y) is important for the priming of macrophages, and tumor necrosis factor a (TNF-a) or some other cytokine or bacterial lipopolysaccharide (LPS) is necessary for full induction of activated macrophage cytotoxicity (6) (7) (8) (9) . However, the role of NO in mediating tumoricidal activity in vivo is not known. We therefore evaluated the in vivo role of NO in mediating both the host resistance to a syngeneic ovarian tumor in BCGinoculated mice as well as the host resistance to a xenogeneic ovarian tumor graft and the role of IFN-y and TNF-a in this process.
We utilized two different ovarian cancer cell lines for our study. The murine ovarian teratocarcinoma (MOT) cell line, utilized to study the mechanism of BCG-induced host resistance to a syngeneic ovarian tumor, spreads throughout the peritoneal cavity and produces ascites in C3HeB/FeJ mice akin to human ovarian cancer (10, 11) . i.p. inoculation of Corynebacterium parvum, which increases nonspecific resistance to MOT tumor cells, can cure mice bearing these tumor cells (12) . In studies related to xenogeneic ovarian tumor grafts, we utilized a human epithelial ovarian cancer cell line, NIH:OVCAR-3. This cell line grows and develops as a lethal tumor only in athymic nude (immunologically incompetent) mice (13) . We therefore transplanted these two cancer cell lines i.p. into female C3HeB/FeJ mice,, which served as our model system.
MATERIALS AND METHODS
Reagents and Media. NG-Methyl-L-arginine acetate (L-NMA), L-and D-arginine hydrochloride, LPS (phenolextracted Escherichia coli, serotype 0.128:B12), minimum essential medium (MEM) without phenol red, sodium nitrate, FAD, NADPH, ammonium chloride, sulfanilic acid, N-(1-naphthyl)ethylenediamine, and Aspergillus nitrate reductase were obtained from Sigma. Glacial acetic acid and sodium nitrite were obtained from Fisher Scientific. Fetal calf serum, L-glutamine, penicillin, streptomycin, and amphotericin B were obtained from Irvine Scientific. BCG (Thera-cys strain) was obtained from Connaught Laboratories. Recombinant murine IFN-y (Mu-rIFN-y) and recombinant murine TNF-a (Mu-rTNF-a) were obtained from International Biosource (Camarillo, CA). Recombinant human IFN-y and recombinant human TNF-a were obtained from Collaborative Biomedical Products (Bedford, MA). Monoclonal antibody to Mu-rIFN--y (IFNyAB), Mu-rTNF-a (TNF-a"), and irrelevant murine immunoglobulin (IgG immunoglobulin isotype standard) were obtained from PharMingen.
Cancer Cell Lines. MOT cell line was obtained from Robert Bast (Duke University, Durham, NC). The MOT cell line is a murine germ-cell tumor, which arose spontaneously in a C3HeB/FeJ mouse (10, 11) . These MOT cells are syngeneic for C3HeB/FeJ mice and were grown in this strain. The human epithelial ovarian cancer cell line NIH:OVCAR-3 (hereafter referred to as OVCAR) was obtained from American Type Culture Collection.
Animals. Six-to 10-week-old female C3HeB/FeJ mice (The Jackson Laboratory) weighing 17-28 g were utilized. These animals were housed five per cage in standard facilities.
In Vivo Studies. Studies related to the mechanism of BCG-induced host resistance to a syngeneic ovarian tumor graft. MOT cells (105) (14) instead of IFN-yAB. Gp V (n = 5) was similar to Gp III but received i.p. irrelevant murine immunoglobulin (200 pug per animal) instead of IFN-YAB. Gp VI (n = 3) and Gp VII (n = 3) were similar to Gp II and, in addition, received i.p. either L-arginine or D-argiline (750 mg/kg of body weight), respectively, daily along with L-NMA. OVCAR cells proliferate slowly and only in athymic nude mice (13) . Experiments were therefore terminated 14 days after OVCAR cell transplantation to ensure adequate time for significant differences in tumor cell numbers to be observed, should this occur among the treatment groups.
Assessment of cancer cell growth in vivo. Animals were weighed initially at the time of tumor cell transplantation and then again just prior to sacrifice. Euthanasia was performed by intracardiac injection of pentobarbital sodium (100 mg/ kg). Through a midline incision, ascitic fluid was collected, followed by four sequential lavages of the peritoneal cavity. The lavage effluent was centrifuged at 250 x g at 8°C for 10 min. The cell pellets were resuspended in Hepes buffer with 0.3% bovine serum albumin, the cells were counted in a hemacytometer, and viability was measured by trypan blue exclusion (20, 21) . Cytopreps were stained with WrightGiemsa and cell differential counts were then performed. (20) . NR8383 macrophages were utilized as our positive control as these cells can be stimulated by cytokines in vitro to produce NO (20) . NO production was indirectly assessed by estimation of nitrite and nitrate concentration in the culture supernatant. Viability of cells was measured by trypan blue exclusion (21) . If viability exceeded 97%, cells were suspended in MEM with 2% fetal bovine serum, 2 mM glutamine, and antibiotics at a density of 5 x 105 cells per ml, and 1 ml was placed into 8 wells of 24-well dishes (Costar). MOT or OVCAR cells were placed in the other 16 wells. A combination of LPS and cytokines (25 A4) was incubated with these cell lines for 22 hr at 37°C in 5% CO2. In some wells, LPS and cytokines were not added and these wells served as our negative controls for each cell type. The combinations of cytokines and LPS were as follows: (i) IFN-y (1000 units/ml per well) and LPS (100 ng/ml per well) or (ii) IFN-y (1000 units/ml per well), LPS (100 ng/ml per well), and TNF-a (1000 units/ml per well). Species-specific recombinant IFN-y and TNF-a were utilized in these experiments.
Assessment of cytokine-induced cytotoxicity in cancer cells studied in vitro. The cytotoxic effect of cytokines on cultured MOT and OVCAR cells was assessed by determining viability using trypan blue exclusion (21) .
Nitrite determinations. Nitrite was measured by the modified Griess reaction (20, 22) . Standard curves were constructed using sodium nitrite concentrations ranging from 0 to 50 p;M in MEM without phenol red (20, 22 Table 1 and Fig. 1 . Significant increase in the number of MOT cells and an increase in body weight accompanied by ascites were observed in control (non-BCG treated) animals (Gp I) and in those preinoculated with s.c. BCG (Gp III). Tumoricidal activity in animals preinoculated with i.p. BCG (Gp II) was evident by a reduction in the number ofviable intraperitoneal MOT cells and absence of ascites. In this group (Gp II), the predominant cell types in the peritoneal washings were macrophages (54%) and lymphocytes (23%) (Fig. 2) . By contrast, daily i.p. administration (250 mg/kg) of L-NMA, an inhibitor of NO synthesis (3, 15, 16) , prevented the tumoricidal activity in animals preinoculated with i.p. BCG and subsequently transplanted with MOT cells (Gp IV) (Fig. 2) . The MOT cells in this group of animals proliferated to the same extent as that of control animals which received MOT cells alone (Gp I). In animals in Gp VIII, the effect of L-NMA was not observed when L-arginine (750 mg/kg), the precursor of NO synthesis (1, (17) (18) (19) , was injected simultaneously with L-NMA (data not shown). D-Arginine (Gp IX) did not reverse the effects of L-NMA (data not shown). These results indicated that the BCG-induced host defense mechanism to MOT cells in vivo was due to stimulation of the L-arginine-NO pathway. IFN-yAB (200 Mg per animal) (14) , administered i.p. In vivo studies related to the mechanism ofhost resistance to a xenogeneic ovarian tumor graft. The results of these experiments are summarized in Fig. 3 . Marked tumoricidal activity was observed in animals (Gp I) transplanted i.p. with OVCAR cells, as evidenced by a significant reduction in the number oftumor cells. No ascites was observed. No mortality was observed in any OVCAR-transplanted animals. The predominant cell types in the peritoneal washings in these control animals were lymphocytes (70%) and macrophages (27%) (Fig. 4) . L-NMA (Gp II) reduced tumoricidal activity (Fig. 4) and resulted in ascites formation. IFN-yAB (Gp III), TNF-aAB (Gp IV) (Fig. 3) or irrelevant murine immunoglobulin (Gp V), did not affect tumoricidal activity (data not shown). L-Arginine reversed the effects of L-NMA (Gp VI), but D-arginine (Gp VII) was without effect (data not shown).
In Vitro Studies. The results of culture and in vitro stimulation of MOT cells, OVCAR cells, and NR8383 cells are summarized in Table 2 . MOT cells, OVCAR cells, and NR8383 cells did not produce detectable nitrite or nitrate in the absence of LPS and cytokines. IFN-y and LPS, in combination or along with TNF-a, activated the macrophages to produce increased nitrite and nitrate. Only very small quantities of nitrite and nitrate were produced by MOT cells and OVCAR cells after stimulation with a combination of LPS and cytokines and the viability of these cells was also not affected. DISCUSSION Studies in vitro indicate that certain cytokines are capable of activating macrophages and inducing synthesis ofNO, thereby exerting cytostatic and/or cytolytic activity (6, 7) . Evidence that L-arginine is the biosynthetic precursor of NO (1, (17) (18) (19) led to the development and utilization of NG-substituted analogs of L-arginine such as L-NMA to inhibit NO synthesis (3, 15, 16) and thereby the study of the physiological and pathophysiological role of NO (14) (15) (16) 24) . The primary objective ofthis study was to assess the role of NO as a mediator for host resistance to both a syngeneic ovarian tumor in BCG-inoculated mice as well as xenogeneic ovarian tumor grafts in vivo. We also assessed the role of certain specific cytokines, IFN-y and TNF-a, as effectors or mediators in these mechanisms in vivo. We studied the role ofNO indirectly by observing the effects of inhibiting NO synthesis by L-NMA and also the ability of a 3-fold excess of L-arginine, but not D-arginine, to stereoselectively reverse the effects of L-NMA (3, 15, 16) . We show the importance of NO in mediating both the BCG-induced host resistance to a syngeneic ovarian tumor as well as the host resistance to xenogeneic ovarian tumor grafts. We also demonstrate that IFN-y, but not TNF-a, is an important mediator of the BCG-induced nonspecific host resistance against syngeneic ovarian tumor cells in vivo. This observation is contrary to in vitro studies in which IFN-y was thought to be important for the priming of macrophages and TNF-a was thought to be necessary for full induction of activated macrophage cytotoxicity (8, 9) . Furthermore, others (14) showed that neutralization of either IFN--y or TNF-a blocked the BCG-induced in vivo synthesis of nitrogen oxides from L-arginine as well as the protection against Francisella tularensis. Our observation that only IFN-YAB, but not TNFaAB, neutralized BCG-induced host resistance to the syngeneic tumor is therefore surprising. Further studies are necessary to explain this possible discrepancy.
We were not able to inhibit the host resistance to the explanation may also hold true with regard to our observation that TNF-aAB had no effect on host resistance to the ovarian xenogeneic tumor graft. However, other potential mechanisms of tumoricidal activity independent of IFN-y and TNF-a may also have been involved in host resistance to xenogeneic ovarian tumor grafts in vivo.
The source of NO responsible for the cytolytic activity in vivo was most likely from activated macrophages (1) (2) (3) 25 (27, 28) . Our results may also explain why s.c. and i.v. administration of BCG to women was not effective for treatment ofhuman ovarian cancer (29) , whereas i.p. instillation of C. parvum, which, like BCG, stimulates the host defense mechanism (30) , was at least partially effective in the treatment of minimal residual ovarian cancer in women (31) . It would, therefore, be interesting to evaluate whether the tumoricidal action in humans is also mediated by NO.
